Beta-Blockers and Exercise Performance in Children With Long QT Syndrome
JACC: Clinical Electrophysiology · 2026-08 · 12 (8) · 2010-2018
DOI: 10.1016/j.jacep.2026.06.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2026-08. Verfasst von Gregory Webster und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois,…. Hauptthemen laut MEDLINE: Long QT Syndrome, Adrenergic beta-Antagonists, Exercise. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, NHLBI.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Young people taking beta-blockers for long QT syndrome (LQTS) have concerns about exercise performance. OBJECTIVES: This study sought to determine whether objective measures of cardiopulmonary fitness are influenced by beta-blocker dose in LQTS. METHODS: In a retrospective chart review of treadmill cardiopulmonary exercise tests (CPETs), we measured peak oxygen consumption (Vo2), respiratory exchange ratio (RER), blood pressure, and percent predicted heart rate at peak exertion (%PHR), each analyzed with a linear mixed-effects model. We analyzed nadolol data (noncardioselective) as our primary analysis, then analyzed a validation cohort of atenolol data (cardioselective). RESULTS: We evaluated 220 CPETs in 93 patients with LQTS. The mean age at first CPET was 12 ± 3.9 years. In multivariable analysis, %PHR decreased by 13% for every 1 mg/kg/d increase in beta-blocker dose, demonstrating physiologic beta-blocker effects. However, we identified no correlation between nadolol dose and measures of cardiopulmonary fitness. Neither peak Vo2 nor peak RER was correlated with nadolol dose. Only mild blood pressure changes were observed (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Electronic address: rgwebster@luriechildrens.org.
- Division of Biostatistics and Informatics, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Corewell Health Helen Devos Children's Hospital, Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA.
- Division of Cardiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- The Heart Center, Nationwide Children's Hospital, Columbus, Ohio, USA.
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
- NHLBI
- NIH
Zitieren
APA
Webster, G., Gill, N., Carberry, T., Chandler, S. F., Cherny, S., Lockhart, E. N., Onorato, A. C., Dillenbeck, H., Ward, K., & Laternser, C. (2026). Beta-Blockers and Exercise Performance in Children With Long QT Syndrome. JACC: Clinical Electrophysiology, 12(8), 2010-2018. https://doi.org/10.1016/j.jacep.2026.06.010
Vancouver
Webster G, Gill N, Carberry T, Chandler SF, Cherny S, Lockhart EN, et al. Beta-Blockers and Exercise Performance in Children With Long QT Syndrome. JACC: Clinical Electrophysiology. 2026;12(8):2010-2018. doi:10.1016/j.jacep.2026.06.010
BibTeX
@article{Webster2026,
author = {Webster, Gregory and Gill, Nathan and Carberry, Thomas and Chandler, Stephanie F and Cherny, Sara and Lockhart, Elli N and Onorato, Angela C and Dillenbeck, Halley and Ward, Kendra and Laternser, Christina},
title = {Beta-Blockers and Exercise Performance in Children With Long QT Syndrome},
journal = {JACC: Clinical Electrophysiology},
year = {2026},
volume = {12},
number = {8},
pages = {2010--2018},
doi = {10.1016/j.jacep.2026.06.010}
}
EUVIMED